Exagen Inc

XGN

Company Profile

  • Business description

    Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

  • Contact

    1261 Liberty Way
    VistaCA92081
    USA

    T: +1 760 560-1501

    https://www.exagen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    179

Stocks News & Analysis

stocks

Competition impacting ASX market darling

Shares tumble after results.
stocks

Ask the analyst: Is the market underestimating Bapcor?

This moated ASX company's shares are in a prolonged slump. I quizzed our analyst Angus Hewitt on its management, the potential impact of EVs, and more.
stocks

Is our ASX best idea still attractive after shares surge?

Shares rose over 21% following the results. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,764.4016.800.19%
CAC 408,006.2233.190.42%
DAX 4021,911.74124.740.57%
Dow JONES (US)44,470.41167.010.38%
FTSE 1008,767.8067.270.77%
HKSE21,492.1429.84-0.14%
NASDAQ19,714.27190.870.98%
Nikkei 22538,801.1714.150.04%
NZX 50 Index12,912.2535.900.28%
S&P 5006,066.4440.450.67%
S&P/ASX 2008,497.2014.400.17%
SSE Composite Index3,312.479.70-0.29%

Market Movers